Dopamine is one of the principal neurotransmitters in the basal ganglia, where it plays a critical role in motor control and cognitive function through its interactions with the speci®c dopamine receptors D 1 to D 5 . Although the activities mediated by most dopamine receptor subtypes have already been determined, the role of the D 5 receptor subtype in the basal ganglia has still not been established. Furthermore, it is often dif®cult to distinguish between dopamine D 5 and D 1 receptors as they are stimulated by the same ligands, and they have a similar molecular structure and pharmacology. In an effort to understand the differences between these two receptor subtypes, we have studied the distribution of neurons containing D 5 receptors in the striatum, and their molecular phenotype. As a result, we show that the D 5 receptor subtype is present in two different populations of striatal neurons, projection neurons and interneurons. Overall, the abundance of this receptor subtype in the striatum is low, particularly in striatal projection neurons of both the direct and indirect projection pathways. In contrast, the expression of D 5 receptors in striatal interneurons (cholinergic, somatostatin-or parvalbumin-positive neurons) is high, while low to moderate expression was observed in calretinin-positive neurons. Our results demonstrate the presence of D 5 receptors in all the striatal cell populations so far described, although at different intensities in each. The fact that a large number of striatal neurons express the D 5 receptor subtype suggests that this receptor ful®ls an important function in the process of integrating information in the striatum.
Introduction
In the basal ganglia the striatum plays a pivotal role in the regulation of motor control, as well as in processing cognitive and emotional inputs. The integration of information within this neural system requires the precise coordination of the activities of striatal projection neurons and interneurons. Dopaminergic inputs from the substantia nigra play a crucial role regulating the activity of all striatal neurons. Dopamine (DA) acts on speci®c G protein-coupled receptors that are grouped into two families based on their biochemical, pharmacological and physiological pro®les: D1-class (D 1 and D 5 subtypes) and D2-class (D 2 , D 3 and D 4 subtypes) (Missale et al., 1998) .
Not all striatal neurons are equally responsive to dopaminergic stimulation. Behavioural sensitization and drug addiction induced by chronic exposure to cocaine involves the activation of D1-class receptors and the expression of immediate early genes in speci®c striatal neurons that express dynorphin or somatostatin but not in cholinergic or enkephalin-positive neurons (Moratalla et al., 1992 (Moratalla et al., , 1996a Uslaner et al., 2001; Centonze et al., 2002) . Striatal cholinergic neurons respond differently, as activation of D1-class receptors induces acetyl choline (ACh) release (Consolo et al., 1992; Acquas & Di Chiara, 1999) . This is due both to depolarization of cholinergic interneurons and to increase in cholinergic synaptic potentials (Consolo et al., 1992; Aosaki et al., 1998; Calabresi et al., 1998; Acquas & Di Chiara, 1999; Pisani et al., 2000; Suzuki et al., 2001; Koos & Tepper, 2002) . In addition, these neurons respond to dopamine-dependentsensory-motor conditioning, a response that is dependent on the stimulation of D 1 -class receptors (Aosaki et al., 1994a,b) . Although it is clear that these effects involve the participation of D 1 -class receptors, it has not been possible to differentiate between D 1 -and D 5 -dependent effects, as there are no speci®c pharmacological agents currently available to discriminate between them.
While the D 1 receptor subtype is much more abundant than the D 5 subtype, the presence of D 5 receptors in the striatum is not negligible because their af®nity for dopamine is ®ve times higher than that of D 1 receptors (Grandy et al., 1991) . The phenotype of neurons that express D 1 receptors is known. These receptors are mainly localized in neurons of the direct pathway and are coexpressed with the neuropeptides substance P and dynorphin (Gerfen et al., 1990; Le Moine et al., 1991; Moratalla et al., 1996b; Fauchey et al., 2000) . However, it has also been suggested that D 1 receptors are signi®cantly expressed in neurons of the indirect pathway (Surmeier et al., 1996; Aizman et al., 2000) . Furthermore, D 1 receptors are weakly expressed on a small number of NOS-positive interneurons in the striatum (Le Moine et al., 1991) . Although it is known that D 5 receptors are expressed in large and medium size striatal neurons (Luedtke et al., 1999; Ciliax et al., 2000; Khan et al., 2000) , the molecular phenotype of these neurons remains unclear. To better understand dopaminergic function in the basal ganglia it is critical to characterize the striatal neurons that express D 5 receptors. In this study, we have identi®ed the molecular phenotype of projection neurons and interneurons that express the D 5 receptor subtype in the rat striatum, and we have compared their distribution in the rat and cat striatum.
Materials and methods

Animals and tissue preparation
Adult male Wistar rats (n = 15) and cats (n = 2) were deeply anaesthetized with sodium pentobarbital (i.p. 60 mg/kg) and perfused intracardially with 4% paraformaldehyde, 75 mM L-lysine and 10 mM sodium meta-periodate in 0.1 M phosphate buffer (PB), pH 7.4. Their brains were removed and post®xed in the same solution overnight at 4°C. The ®xed brains were cryoprotected with 30% sucrose in 0.1 M phosphate-buffered saline (PBS), frozen in dry ice and sectioned (30 mm thick) with a freezing microtome (CM 1325, Leica, Germany) . Coronal sections through the striatum were collected and stored in PBS with 0.02% sodium azide at 4°C for either singleor double-label immunocytochemistry. All the studies were approved by the appropriate animal care committee at the Cajal Institute, CSIC, and all efforts were made to minimize the number of animals used.
Antisera
To localize D 5 dopamine receptors we have used a monoclonal antibody against the D 5 receptor (1 : 50 dilution, Chemicon, Temecula, CA, USA; Luedtke et al., 1999) and a polyclonal rabbit antiserum speci®c for the D 5 receptor previously developed and characterized in our laboratory (1 : 500 and 1 : 1000 dilutions; Khan et al., 2000) .
Striosomes were identi®ed with a polyclonal rabbit antiserum against the m-opioid receptor 1 (MOR1; 1 : 50 000 dilution, provided by R. Elde, University of Minnesota, MN, USA; Arvidsson et al., 1995; Tan et al., 2000) . To identify striatal projection neurons, we used a polyclonal rabbit antiserum against dynorphin B for the neurons of the direct pathway (1 : 5000 dilution, Peninsula Laboratories, Belmont, CA, USA) and a polyclonal rabbit antiserum against met-enkephalin for the neurons of the indirect pathway (1 : 1000 dilution, Instar, Stillwater, MN, USA). To identify striatal interneurons, a polyclonal goat antiserum against choline acetyltransferase was used to identify cholinergic neurons (ChAT; 1 : 1000 dilution; Chemicon, Temecula, CA, USA; Rico & Cavada, 1998) . We also used a monoclonal rat antibody against somatostatin (SS; 1 : 50 dilution; provided by J. Rodrigo and A. C. Cuello, Cajal Institute, CSIC, Spain; Milstein & Cuello, 1983) , a monoclonal mouse antibody against parvalbumin (PV; 1 : 1000 dilution; Sigma), and a polyclonal goat antiserum against calretinin (CR; 1 : 1000 dilution; Swant, Bellinzona, Switzerland). All primary antibodies were diluted in 0.1 M PBS, with 0.2% Triton X-100 (PBS-TX) and 0.1% sodium azide.
Immunohistochemical procedures
Single antigen immunohistochemistry was performed to localize D 5 dopamine receptors in sections of the rat and cat striatum. Endogenous peroxidase activity was quenched by incubation for 10 min with 3% hydrogen peroxide in PBS. After washing with PBS, sections were incubated for 72 h at 4°C in anti-D 5 polyclonal antiserum or monoclonal antibodies. Control sections were incubated in PBS-TX only or with primary antibody previously preadsorbed with the immunizing peptide (Khan et al., 2000) . To visualize the antibody distribution, the sections were washed in PBS, incubated for 1 h in either biotin conjugated goat anti-rabbit IgG diluted 1 : 500 (Vector, Burlingame, CA) or biotin conjugated horse anti-mouse IgG diluted 1 : 200 in PBS-TX. The sections were washed again and incubated for 1 h in a streptavidin-peroxidase complex (Sigma) diluted 1 : 2000 in PBS-TX. Peroxidase activity was visualized with 0.05% 3,3¢-diaminobenzidine (DAB, Sigma) and 0.002% H 2 O 2 , and the staining was intensi®ed with 0.8% nickel ammonium sulfate. The sections were mounted on gelatin-coated slides, air dried, dehydrated with ethanol, cleared in xylene and coverslipped with DPX mounting medium. Similar results were obtained when the polyclonal D 5 receptor antiserum was incubated overnight at a dilution of 1 : 500.
Double-labelling immunostaining with MOR1 and D 5
Two-colour dual antigen immunostaining was carried out to visualize D 5 immunoreactivity in cells of the striosomal compartment of the striatum labelled with the MOR1 antiserum. We used the protocol described previously in which sequential staining was performed (Moratalla et al., 1996a; Rivera et al., 2002) . Immunodetection of D 5 receptors was performed ®rst and visualized with DAB and nickel ammonium sulfate, yielding a dark purplish precipitate. We then carried out immunostaining for the MOR1 antigen that was visualized with DAB yielding a brown precipitate.
Double-labelling immunocytochemistry with¯uorescence secondary antibodies
Double-labelling immunocytochemistry was performed in the rat sections. Non-speci®c binding sites were blocked for 30 min with 5% bovine serum albumin in PBS-TX. Sections were washed and incubated with the polyclonal or monoclonal anti-D 5 antiserum 72 h at 4°C and then washed again. The antibody distribution was detected using an Alexa-conjugated secondary antibody diluted 1 : 1000 in PBS-TX and incubated for 1 h (see Table 1 ). The sections were then incubated for 1 or 2 nights, in the dark, with antiEnk, anti-Dyn, anti-ChAT, anti-PV, anti-SS or anti-CR. After washing, the sections were further incubated for 1±2 h in the appropriate Alexa-conjugated secondary antibody (Molecular Probes, Eugene, OR, USA) diluted 1 : 1000 in PBS-TX (see Table 1 ). In each experiment, the speci®city of staining was controlled by incubating sections with one primary antibody and then with both secondary antibodies, to detect any cross-reaction between the antibodies. Sections were mounted in PBS : glycerol (1 : 1) and 2% DABCO (Sigma), coverslipped, and observed by laser confocal microscopy (Leica TCS-NT, Germany). 
Image analysis
The speci®c immuno¯uorescence of the¯uorophores Alexa 488 or Alexa 568/598 was visualized by excitation at the blue ( 
Quantitative and statistical analyses
The number of neurons containing D 5 receptors was analyzed quantitatively and compared between the striosomes and the matrix of the rat striatum. Samples were taken from coronal sections of ®ve different rats. Cell counts and measurements of striatal areas were performed for both compartments with an image analysis system (Visiolog 5.1.1, Noesis, Paris). Before counting, images were thresholded at a standardized grey scale level empirically determined by two independent observers to allow detection of stained cells from low to high intensity, with suppression of negative cells. The number of positive cells per mm 2 was determined in the striosomes and compared with that obtained in the matrix. Statistical differences were determined by Student's t-test (P < 0.05).
Quantitative analysis was also performed to determine the percentage colocalization of ChAT, SS, PV or CR with the D 5 receptor subtype in the rat striatum and nucleus accumbens. Quanti®cation was performed on a confocal microscope at a magni®cation of 20Q. All striatal interneurons positive for ChAT, SS, PV or CR were counted in two sections (four hemispheres), from the rostral, middle and caudal levels of the striatum from ®ve different rats. The presence of the D 5 receptor subtype was assessed by the yellow colour under confocal microscopy. The quantative differences between the receptor colocalization at the three different levels of the striatum were analyzed with a percentage comparison test (Lamotte, 1988) .
Results
Localization of D 5 dopamine receptor in the rat and cat striatum
Immunostaining using either the polyclonal antiserum produced in our laboratory (Khan et al., 2000) or the commercial monoclonal antibody against the D 5 receptor (Chemicon, Temecula, CA) yielded an identical pattern of D 5 receptor expression in the rat striatum. In both cases we detected weak staining of medium size striatal cells, whereas large cells were stained more intensely. The identical distribution patterns and similar differential staining intensity between medium and large cells re¯ects the speci®city of the antibodies, despite the fact that they were raised in different species and against different epitopes of the antigen (Luedtke et al., 1999; Khan et al., 2000) . Dopamine D 5 receptor immunoreactivity (D 5 IR) was mainly associated to neuronal cell bodies in the rat striatum, in both the caudoputamen and nucleus accumbens (Fig. 1A) . In the latter, moderate labelling was also observed in the neuropil. A similar distribution and intensity of D 5 IR was observed in the cat caudate nucleus and putamen (Fig. 1C) . In both species, D 5 -positive neurons were homogeneously distributed throughout the rostro-caudal, dorsoventral and latero-medial axis of the striatum. No differences were observed in the density of D 5 IR neurons between striosomes (900 T 223 neurons/mm 2 ) and the matrix (939 T 246 neurons/mm 2 ; Fig. 2 ).
The D 5 -positive striatal neurons displayed different morphologies and two populations of neurons were readily distinguished. One population was composed of medium-size neurons (around 10 mm diameter) that displayed weak staining. In these cells, D 5 IR was mainly found in the peripheral regions of the somata and occasionally, in the primary dendrites. The labelling was punctate, consistent with the typical staining for receptors ( Fig. 1B and D ). This population of neurons was the most abundant and represented approximately 90% of the total D 5 -positive neurons. The second population corresponds to large-size neurons (around 25 mm diameter). D 5 IR in these neurons was very intense covering the entire cytoplasm and the primary dendrites demonstrating a punctate distribution of D 5 receptors (Fig. 1B and D) . This population represented approximately 10% of all D 5 -positive striatal neurons. Both populations were observed in the rat and cat striatum with no apparent differences between species. Similar observations have been made in the mouse and in all these species, D 5 IR in the striatum was weaker than in the cortex or the hippocampus (data not shown).
Expression of D 5 dopamine receptor subtype in identi®ed striatal projection neurons
We next set out to identify the molecular phenotype of the different striatal neurons that express D 5 receptors in the rat striatum. Phenotype of D 5 -positive neurons in the striatum 2051 colocalized with dynorphin or enkephalin. Analysis of these experiments by confocal microscopy revealed that almost all enkephalinpositive neurons were also positive for D 5 receptors (Fig. 3A±C) .
However, in these experiments, a substantial number of neurons only expressed D 5 receptors (Fig. 3C) . With respect to dynorphin, a high percentage of dynorphin-positive neurons were also immunoreactive for D 5 receptors (Fig. 3D±F) . No difference in D 5 receptor content, as assessed by the intensity of the staining, was evident between dynorphin-and enkephalin-positive neurons (see below). Together, these experiments indicate that D 5 receptors are expressed in neurons of the direct and indirect striatal output pathways at similar weak intensity.
Expression of D 5 dopamine receptors in striatal interneurons
To determine if the large-size neurons that contain D 5 receptors belong to one or more types of striatal interneurons, we carried out double immunolabelling experiments to determine whether the polyclonal D 5 antiserum colocalized with antibodies speci®c for each of the classes of striatal interneurons. We found that D 5 receptors are expressed in all striatal interneurons, but differences were observed in the number and the pattern of colocalization between each interneuronal class. Moreover, differences in signal intensity for the various types of interneurons were also evident.
Cholinergic interneurons
Double immunocytochemical studies showed that all ChAT interneurons in the caudoputamen and nucleus accumbens express D 5 receptors (Table 2) . ChAT interneurons expressed D 5 IR in both cell bodies and dendrites, and displayed the most intense levels when compared to other neuronal populations expressing D 5 receptors (Fig. 4A±C) . Numerous double-labelled neurons (D 5 -and ChATpositive) neurons were also observed outside the striatum, especially in the diagonal band of Broca (data not shown). Thus, cholinergic neurons exhibit the highest dopamine D 5 receptor content in the striatum.
GABAergic interneurons containing SS, NPY and NOS
While in the striatum, a substantial number of SS interneurons were D 5 -positive (Fig. 4D±F) , other SS neurons did not express D 5 receptors (Fig. 4J±L) . Because the morphology of SS interneurons varies, we analyzed whether these two types of neurons (SS-positive/ D 5 -positive and SS-positive/D 5 -negative) were also different with respect to their morphology. No correlation between SS morphology and D 5 receptor expression was evident. Dense D 5 IR was observed in the cell bodies of SS interneurons, and occasionally in primary dendrites. The percentage of SS cells expressing D 5 receptors was 69.4% T 6.0 in the caudoputamen and 83.2% T 13.8 in the nucleus accumbens (Table 2 ). This degree of colocalization was uniform throughout the rostro-caudal axis of the caudoputamen (Fig. 6A) and nucleus accumbens. While double-labelled cells were located preferentially in the medial striatum, SS interneurons lacking D 5 receptors were scattered and mainly located in the lateral striatum (Fig. 6B) . A graphical representation of the distribution of single (SSpositive) and double (SS-and D 5 -positive) labelled-cells is depicted in Fig. 6B .
GABAergic interneurons containing PV
A high degree of colocalization of PV IR and D 5 IR was observed in striatal neurons (Fig. 5A±C ). D 5 IR was seen only in cell bodies in PV interneurons. Quanti®cation analysis of the double-labelled interneurons demonstrated that 73.1 T 16.3% of PV-positive neurons express D 5 receptors in the caudoputamen and 85.2 T 7.4% in the nucleus accumbens (Table 2) . Rostral sections showed a higher percentage of colocalization (92.3 T 6.1%) than caudal sections (57.2 T 3.3%; Fig. 6C ). Statistical analysis showed that differences in the number of D 5 -and PV-positive neurons between rostral, middle, and caudal levels of the striatum were signi®cant (P < 0.01, percentage comparison test). Moreover, double-labelled cells were more abundant in the lateral striatum where a latero-medial gradient was observed (Fig. 6D) .
GABAergic interneurons containing CR
Although GABAergic interneurons containing CR also express D 5 receptors (Fig. 5D±F) , colocalization of both proteins was less frequent than that observed for the other striatal interneurons. The percentage of colocalization was 47.6 T 9.1% in the caudoputamen and 49.6 T 12.4% in the nucleus accumbens (Table 2) . Doublelabelled CR-and D 5 -positive cells were homogeneously distributed in both regions (Fig. 6E and F) . The percentages of colocalization of D 5 receptors with each neuronal phenotype, as well as the distribution of double-labelled cells were consistent across the ®ve animals used in this experiment.
Finally, we carried out a semiquantitative analysis to evaluate the relative intensity of D 5 IR found in the different neuronal populations studied. The intensity of D 5 IR in ChAT neurons was twofold higher than that found in medium size neurons, while in SS and PV neurons it was approximately 70 T 6.2% higher than that in medium size neurons. The intensity of D 5 IR in CR interneurons was similar to that observed in medium sized neurons, differing only by 8.7 T 2.2%. D 5 IR in dynorphin-positive cells was 6 T 4% more intense than in enkephalin-positive neurons. For each set of double-labelling experiments, a minimum of 10±15 interneurons and 20±30 medium size neurons were quanti®ed.
Discussion
Distribution of the D 5 dopamine receptor subtype in the striatum
We have shown here that D 5 -positive cells are distributed in a rather homogeneous manner in the rat and cat striatum, in contrast to the pattern that we have reported for the dopamine D 4 receptors (Rivera et al., 2002) . This homogeneity was similar in both species, and is in agreement with previous reports of the immunocytochemical distribution of this receptor in the rat and monkey striatum (Bergson et al., 1995a ,b Ariano et al., 1997 Luedtke et al., 1999; Ciliax et al., 2000; Khan et al., 2000) . However, in earlier in situ hybridization studies and receptor autoradiography studies, authors were unable to detect D 5 receptors in the rat striatum (Tiberi et al., 1991; Meador-Woodruff et al., 1992; Montague et al., 2001) . These discrepancies are most probably due to the different techniques used to detect D 5 receptors or to the low resolution of ®lm autoradiography. In addition, some species differences may exist, as there is strong evidence that D 5 receptor transcripts are expressed in striatal cells in the monkey (Huntley et al., 1992; Rappaport et al., 1993; Choi et al., 1995) . Phenotype of D 5 -positive neurons in the striatum 2055
These authors also found that the levels of expression of D 5 mRNA in the striatum were lower than in the cortex or in the lateral thalamus. This is in agreement with the lower levels of D 5 IR that we found in the striatum when compared to the cortex or the thalamus. The large difference that we observed in the intensity of D 5 receptor IR between medium and large striatal cells is in agreement with that previously reported in several species, including rat, monkey, and humans (Rappaport et al., 1993; Luedtke et al., 1999; Ciliax et al., 2000; Khan et al., 2000) . However, we have now extended these observations to the cat. Interestingly, this immunocytochemical data correlates with the differences in the number of D 5 receptor transcripts found by in situ hybridization in large neurons when compared to medium size neurons in the monkey striatum (Rappaport et al., 1993) . Taken together these results indicate that the levels and the pattern of expression of the D 5 receptor subtype is conserved in the mammalian brain, moreover, they support a similar functional role for D 5 receptors in the basal ganglia complex of all these species.
Dopamine D 5 receptor expression in the direct and indirect striatal output pathways
The presence of D 5 receptors in neurons of the direct and indirect striatal output pathways demonstrated here has important implications. Psychomotor behavioural synergism has been reported in several studies following D 1 and D 2 receptor stimulation, both in normal and in dopamine-depleted animals. This phenomenon has been dif®cult to explain, as the available evidence indicates that each one of these receptor subtypes are segregated in different striatal output pathways. Therefore, it has been proposed that an indirect mechanism exists, mediated by inter±neuronal interactions, that involves the activation of D 1 and D 2 receptors on separate populations of striatal neurons, striatonigral and striatopallidal neurons (Gerfen et al., 1995) . Although these interactions are feasible through the synaptic connections that are established between these two neuronal populations (Yung et al., 1996) , our ®nding that D 5 receptors are expressed in enkephalinergic neurons that also express D 2 receptors provides another possible explanation for the D 1 /D 2 synergism. As such, this synergism might arise through the stimulation of D 5 and D 2 receptor subtypes within the same cell, given that D 1 and D 5 receptors are stimulated by the same ligands and are coupled to identical transduction pathways (Grandy et al., 1991; Sunahara et al., 1991; Tiberi et al., 1991) . This direct mechanism would not exclude other possible interactions (see, Alonso et al., 1999) and at present, represents only a further possibility as our results do not allow us to reach any solid conclusion. Further work will be necessary to explore and consolidate this hypothesis.
A similar direct synergism between D 5 /D 2 receptor subtypes has been documented Svenningsson & Le Moine, 2002) . These authors found that combined treatment with SKF-82958, a D 1 /D 5 agonist, and quinelorane, a D 2 receptor agonist, induced c-fos mRNA expression in a large number of cholinergic interneurons, while treatment with either of these two agonists alone had only a minor effect. Because D 2 and D 5 dopamine receptors colocalize in these neurons, these results provide further evidence that a synergistic effect mediated through these receptors could occur within the same neuron. Our results are consistent with the existence of an intracellular pathway that would mediate D 5 /D 2 synergism in medium sized neurons.
It should also be taken into account that SKF-82958, a full agonist of D 1 /D 5 receptors, up-regulates c-fos mRNA expression in striatonigral (dynorphin-positive) and in striatopallidal (enkephalinpositive) neurons . This result correlates with our ®nding that D 5 receptors are expressed in enkephalinpositive neurons in the striatum. It is important to note that c-fos mRNA is induced in both enkephalinergic and dynorphin neurons through the interaction with a full agonist of class D1 receptors as previous experiments using a partial agonist, SKF 38393, failed to detect c-fos expression in enkephalinergic neurons. Indeed, these results provide strong evidence that D 5 receptors are both present and functional in striatal enkephalinergic neurons.
Certain controversy exists regarding the colocalization of the two major receptor subtypes, D 1 and D 2 , in the same cells (Gerfen et al., 1990; Le Moine et al., 1991; Surmeier et al., 1992 Surmeier et al., , 1996 Aizman et al., 2000) . Most of the experiments supporting the colocalization of these two receptors are heavily based on functional studies in isolated striatal neurons, where D1-and D2-class agonists were frequently found to modulate voltage dependent Ca 2+ channels in the same cell (Surmeier et al., 1992 (Surmeier et al., , 1996 Aizman et al., 2000) . These results have been interpreted as evidence for coexpression of D 1 and D 2 receptor subtypes without taking into consideration the presence of other receptor subtypes such as the D 5 receptor, which is also able to respond to D1-class receptor ligands. Our results indicate that the electrophysiological effects of these D1-class ligands might be mediated by stimulation of D 5 receptors. Performing similar electrophysiological studies in the D 1 KO mice would help to clarify this important issue.
D 5 dopamine receptors modulate dopaminergic function in striatal interneurons
The presence of D 5 receptors in large striatal neurons has been described previously (Rappaport et al., 1993; Bergson et al., 1995a,b; Khan et al., 2000) . However, the cholinergic phenotype of these neurons had been inferred on the basis of their large size. The results described in this paper provide unequivocal evidence of the molecular identity of these D 5 receptor-expressing neurons, con®rming their cholinergic nature. In addition, we found that all the other types of chemically de®ned striatal GABAergic interneurons expressing parvalbumin, somatostatin or calretinin (Kawaguchi et al., 1995) also express this receptor. The precise regional distribution of the colocalization with D 5 receptors, medially for SS/NPY/NOS and dorsolateral for PV, may re¯ect the differential D 5 -mediated dopaminergic modulation of neostriatal circuits. Alternatively, this distribution may simply be the result of the typical distribution of each class of interneurons with which the D 5 receptor colocalizes.
The functional role of D 5 receptors in all these classes of interneurons has not been established. Cholinergic and somatostatinpositive neurons receive inputs from the thalamus (Lapper & Bolam, 1992) and the cortex (Vuillet et al., 1989) , respectively, and make contacts with projection neurons and interneurons (Bolam et al., 2000) . For this reason, and due to the profuse arborization and the length of their axons, it has been proposed that these neurons may correspond to associative neurons previously thought not to be present in the striatum (Kawaguchi et al., 1995) . Strikingly, somatostatin-and ChAT-positive neurons exhibit the highest levels of D 5 receptor expression among striatal interneurons, suggesting that the functions of these associative neurons could be mediated through D 5 receptors.
The existence of ACh/DA interactions within the striatum has been well documented (Di Chiara et al., 1994) . Pharmacological studies demonstrate that D1-and D2-class receptors play different roles in ACh/DA interactions. Agonists of D2-class receptors inhibit ACh release (Bertorelli & Consolo, 1990; Acquas & Di Chiara, 1999) , consistent with the presence of D 2 receptor subtypes in cholinergic interneurons (Le Moine et al., 1990; Aubry et al., 1993; MacLennan et al., 1994; Aubert et al., 2000) . In contrast, ligands of D1-class receptors facilitate ACh release (Bertorelli & Consolo, 1990; Damsma et al., 1990; Acquas & Di Chiara, 1999) , despite the fact that D 1 receptors are not present in cholinergic interneurons (Le Moine et al., 1991; Yan & Surmeier, 1997) . Therefore, the dopamine-stimulated release of ACh from striatal cholinergic neurons could be due, as our data suggest, to D 5 receptor stimulation, as D 5 receptors are present at high density and in all cholinergic neurons in the striatum. Further experimental work will be necessary to establish the role of D 5 receptors in the release of ACh in the striatum. However, it is important to point out that a similar situation has been described in the hippocampus, where, using antisense oligonucleotides against D 1 and D 5 receptors, it has been demonstrated that ACh release is regulated by the stimulation of D 5 receptors (Hersi et al., 2000) .
In addition, cholinergic neurons respond to classical conditioning paradigms, where a sensory stimuli is associated with a reward during the learning process (Aosaki et al., 1994b) . This response is dependent upon dopaminergic input from the cell groups of the midbrain, and it is maintained for a long time after learning (Aosaki et al., 1994b) . This long-term maintenance of the conditioned response could be due to a dopamine-dependent long-term change in the synaptic ef®ciency of striatal neurons. In fact, it has recently been shown that high frequency stimulation induces long-term potentiation (LTP) in the striatum Centonze et al., 2001) , and in particular in cholinergic neurons (Aosaki et al., 1998; Suzuki et al., 2001) . This change in the synaptic ef®ciency of cholinergic neurons induced by LTP is dependent on D1-class receptor stimulation but not on NMDA receptor stimulation. As these cells do not express D 1 type receptors, our results indicate that D 5 receptors must be those that modulate this response. Therefore, an involvement of D 5 receptors in the long term memory process coupled to associative learning can now be proposed.
Taking these results together, it appears that a segregation of neurons expressing D 1 and D 5 receptor subtypes exists in the striatum. While D 1 receptors are highly expressed in projection neurons, D 5 receptors are mostly present in interneurons. Interneurons are a fundamental component for striatal function because they modulate the activity of projection neurons. The high percentage of D 5 receptors in interneurons implies a relevant role for this receptor subtype in the regulation of striatal activity. In addition, molecular genetic approaches using antisense oligonucleotides against D 1 and D 5 receptors or KO mouse technology for D 1 receptors, have revealed a different role for each receptor subtype in the control of locomotion (Drago et al., 1994; Xu et al., 1994; Dziewczapolski et al., 1997; Hersi et al., 2000) . In summary, our results together with those in the literature suggest that D 1 and D 5 receptor subtypes, by virtue of being expressed in different neurons, may subserve different roles in the striatal dopaminergic transmission, despite being stimulated by the same ligands and sharing signal transduction pathways.
